Digestive Diseases and Sciences

Editor’s Comments
pp. 839-839(1)
Author: Wechsler R.L.

Returning Control of Health Care to the Patient-Physician Nexus
pp. 840-844(5)
Author: Farrar J.T.

Rabeprazole Versus Omeprazole in Preventing Relapse of Erosive or Ulcerative Gastroesophageal Reflux Disease
pp. 845-853(9)
Authors: Thjodleifsson B.; Beker J.A.; Dekkers C.; Bjaaland T.; Finnegan V.; Humphries T.J.

Significance of Autonomic Nervous System Activity in Functional Dyspepsia
pp. 854-863(10)
Authors: Muth E.R.; Koch K.L.; Stern R.M.

Cyclin D1 Expression Is Useful as a Prognostic Indicator for Advanced Esophageal Carcinomas, but Not for Superficial Tumors
pp. 864-869(6)
Authors: Toyoda H.; Nakamura T.; Shinoda M.; Suzuki T.; Hatooka S.; Kobayashi S.; Ohashi K.; Seto M.; Shiku H.; Nakamura S.

Establishment of Novel Human Esophageal Cancer Cell Line in Relation to Telomere Dynamics and Telomerase Activity
pp. 870-879(10)
Authors: Kiyozuka Y.; Asai A.; Yamamoto D.; Senzaki H.; Yoshioka S.; Takahashi H.; Hioki K.; Tsubura A.

Neutrophil Accumulation in Development of Gastric Ulcer Induced by Submucosal Injection of Endothelin-1 in Rats
pp. 880-888(9)
Authors: Watanabe T.; Arakawa T.; Tominaga K.; Fujiwara Y.; Higuchi K.; Kuroki T.

Letter: Pathogenesis of Increased Sucrose Permeability in H. Pylori Gastritis
pp. 889-889(1)
Author: Graham D.Y.

Obesity Potentiates AOM-Induced Colon Cancer
pp. 890-895(6)
Authors: Weber R.V.; Stein D.E.; Scholes J.; Kral J.G.

Effect of Cholesterol Levels on Villous Histology in Colonic Adenomas
pp. 896-899(4)
Authors: Houghton J.; Lardieri G.G.; Zauber N.P.; Kim K.H.; Cable G.

Carcinoma of the Gallbladder—Is It a Sequel of Typhoid?
pp. 900-903(4)
Authors: Shukla V.K.; Singh H.; Pandey M.; Upadhyay S.K.; Nath G.

Stimulation of Gallbladder by Intravenous Infusion of Amino Acid: A New Method to Obtain Duodenal Bile for Bile Analyses
pp. 904-908(5)
Authors: Garg P.K.; Goindi G.; Tandon R.K.

Effect of Peritoneal Lavage and Lymph Ligature on Systemic Complications of Experimental Acute Pancreatitis
pp. 909-914(6)
Authors: Folch E.; Closa D.; Gelpí E.; Roselló-Catafau J.

Lipopolysaccharide Directly Affects Pancreatic Acinar Cells
pp. 915-926(12)
Authors: Vaccaro M.I.; Calvo E.L.; Suburo A.M.; Sordelli D.O.; Lanosa G.; Iovanna J.L.

Cytokine Production by CAPAN-1 and CAPAN-2 Cell Lines
pp. 927-932(6)
Authors: Blanchard II J.A.; Barve S.; Joshi-Barve S.; Talwalker R.; Gates L.K.

Case Report: Increased Serum Leptin by Cholecystitis in a Diabetic Patient
pp. 933-936(4)
Authors: Moriya M.; Okumura T.; Motomura W.; Takahashi N.; Kitagawa T.; Kohgo Y.

Erythromycin Enhances Solid-Phase Gastric Emptying in Induced-Hyperglycemia in Patients with Truncal Vagotomy and Pyloroplasty
pp. 937-945(9)
Authors: Petrakis I.E.; Vrachassotakis N.; Vassilakis S.J.; Sciacca V.; Chalkiadakis G.

Cholera Toxin-Induced Secretion in Rats Is Reduced by a Soluble Fiber, Gum Arabic
pp. 946-951(6)
Authors: Turvill J.L.; Wapnir R.A.; Wingertzahn M.A.; Teichberg S.; Farthing M.J.G.

Sleep Disturbance Influences Gastrointestinal Symptoms in Women with Irritable Bowel Syndrome
pp. 952-959(8)
Authors: Jarrett M.; Heitkemper M.; Cain K.C.; Burr R.L.; Hertig V.

Effects of Several Endothelin Receptor Antagonists on Gastrointestinal Transit of Guinea Pigs
pp. 960-966(7)
Authors: Kuwahara K.; Kitsukawa Y.; Suzuki Y.; Saito Y.

Effects of Free Radicals and Leukocytes on Increases in Blood–Brain Barrier Permeability During Colitis
pp. 967-975(9)
Authors: Hathaway C.A.; Percy W.H.; Williams J.L.

Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis
pp. 976-981(6)
Authors: Vernia P.; Monteleone G.; Grandinetti G.; Villotti G.; Di Giulio E.; Frieri G.; Marcheggiano A.; Pallone F.; Caprilli R.; Torsoli A.

Prediction of Short-Term Outcome for Patients with Active Ulcerative Colitis
pp. 982-986(5)
Authors: Oshitani N.; Matsumoto T.; Jinno Y.; Sawa Y.; Hara J.; Nakamura S.; Arakawa T.; Kitano A.; Kuroki T.

Recombinant Factor XIII Improves Established Experimental Colitis in Rats
pp. 987-997(11)
Authors: D’argenio G.; Grossman A.; Cosenza V.; Della Valle N.; Mazzacca G.; Bishop P.D.

Case Report: Persistent Clostridium difficile Colitis: A Possible Etiology for the Development of Collagenous Colitis
pp. 998-1001(4)
Authors: Khan M.A.; Brunt E.M.; Longo W.E.; Presti M.E.

Estimation of Nitrate Metabolism in Intestinal Tract by Measuring BreathNitrous Oxide Concentrationin Chinese and Japanese
pp. 1002-1005(4)
Authors: Mitsui T.; Kato N.; Kondo T.

CASE REPORT: Improvement of Chronic Diarrhea After Treatment for Intestinal Spirochetosis
pp. 1006-1010(5)
Authors: Peghini P.L.; Guccion J.G.; Sharma A.

Letter: Oral or Intravenous Lidocaine Administration to Perform MEGX Test?
pp. 1011-1012(2)
Authors: Giannini E.; Botta F.; Romagnoli P.; Testa R.

Endoscopic, Ultrasonographic, and US-Doppler Parameters as Indicators of Variceal Bleeding in Patients with Schistosomiasis
pp. 1013-1018(6)
Authors: Martins R.D.; Szejnfeld J.; Lima F.G.; Ferrari A.P.

48-Hour Hemodynamic Effects of Octreotide on Postprandial Splanchnic Hyperemia in Patients with Liver Cirrhosis and Portal Hypertension
pp. 1019-1027(9)
Authors: Ludwig D.; Schãdel S.; Brning A.; Schiefer B.; Stange E.F.

Nature and Behavior of Serum Cytokines in Type 1 Autoimmune Hepatitis
pp. 1028-1035(8)
Authors: Czaja A.J.; Sievers C.; Zein N.N.

Case Report: Reversible Nefazodone-Induced Liver Failure
pp. 1036-1038(3)
Authors: Eloubeidi M.A.; Gaede J.T.; Swaim M.W.

Case Report: Severe but Reversible Hepatitis Induced by Troglitazone
pp. 1039-1042(4)
Authors: Schiano T.; Dolehide K.; Hart J.; Baker A.L.

News and Notices
pp. 1043-1043(1)